NCT04396873View on ClinicalTrials.gov

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

August 17, 2021

Primary Completion Date

April 11, 2029

Study Completion Date

October 3, 2030

Conditions
Parkinson's DiseaseDementiaAlzheimer's DiseaseALSMild Cognitive Impairment
Interventions
DRUG

11C-MC1

Injected IV followed by PET scanning

DRUG

11C-PS13

Injected IV followed by PET scanning

DRUG

18f-florbetaben

Injected IV followed by PET scanning

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH